Akari Therapeutics Plc
Long

Akari Therapeutics Announces Positive Interim Data from Phase II

154
AKTX: Akari Therapeutics Plc
2020-01-10 09:30:09
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.